Advertisement
Screener

China SXT Pharmaceuticals, Inc. (SXTC) Form 6-K: Report of foreign private issuer

1.0 / 5 stars · 6/29 Roast Me

Add as a preferred source on Google

China SXT Pharmaceuticals, Inc. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-08-28: Form 6-K; Period of report 2026-08-28; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0303801-6k_china.htm.
  • 2026-07-24: Form 6-K; Period of report 2026-07-24; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0299108-6k_chinasxt.htm.
  • 2026-07-06: Form 6-K; Period of report 2026-07-06; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0296876-6k_chinasxt.htm.
  • 2026-06-01: Form 6-K; Period of report 2026-06-01; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0292898-6k_chinasxt.htm.
FiledFormPeriod of reportDescriptionDocument
2026-08-286-K2026-08-28REPORT OF FOREIGN PRIVATE ISSUERea0303801-6k_china.htm
2026-07-246-K2026-07-24REPORT OF FOREIGN PRIVATE ISSUERea0299108-6k_chinasxt.htm
2026-07-066-K2026-07-06REPORT OF FOREIGN PRIVATE ISSUERea0296876-6k_chinasxt.htm
2026-06-016-K2026-06-01REPORT OF FOREIGN PRIVATE ISSUERea0292898-6k_chinasxt.htm
2026-05-046-K2026-05-04REPORT OF FOREIGN PRIVATE ISSUERea0288942-6k_chinasxt.htm
2026-04-096-K2026-04-09REPORT OF FOREIGN PRIVATE ISSUERea0285552-6k_chinasxt.htm
2026-01-136-K2026-01-13REPORT OF FOREIGN PRIVATE ISSUERea0272506-6k_chinasxt.htm
2025-12-316-K2025-09-30REPORT OF FOREIGN PRIVATE ISSUERea0270990-6k_chinasxt.htm
2025-07-296-K2025-07-29REPORT OF FOREIGN PRIVATE ISSUERea0250589-6k_chinasxt.htm
2025-07-156-K2025-07-15CURRENT REPORTea0249000-6k_china.htm
2025-06-166-K2025-06-16REPORT OF FOREIGN PRIVATE ISSUERea0245847-6k_chinasxt.htm
2025-05-136-K2025-05-13REPORT OF FOREIGN PRIVATE ISSUERea0241899-6k_chinasxt.htm
2025-03-286-K2024-09-30REPORT OF FOREIGN PRIVATE ISSUERea0235714-6k_china.htm
2025-03-196-K2025-03-19REPORT OF FOREIGN PRIVATE ISSUERea0234442-6k_chinasxt.htm
2025-01-276-K2025-01-27REPORT OF FOREIGN PRIVATE ISSUERea0228757-6k_chinasxt.htm
2025-01-236-K2025-01-23REPORT OF FOREIGN PRIVATE ISSUERea0228210-6k_chinasxt.htm
2024-10-156-K2024-10-15REPORT OF FOREIGN PRIVATE ISSUERea021764901-6k_chinasxt.htm
2024-05-146-K2024-05-14REPORT OF FOREIGN PRIVATE ISSUERea0205985-6k_chinasxt.htm
2024-04-056-K2023-09-30REPORT OF FOREIGN PRIVATE ISSUERea0202804-6k_chinasxt.htm
2023-03-236-K2023-03-23REPORT OF FOREIGN PRIVATE ISSUERea174850-6k_chinasxt.htm
2023-02-286-K2023-02-28CURRENT REPORTea174411-6k_chinasxt.htm
2023-02-246-K2022-09-30REPORT OF FOREIGN PRIVATE ISSUERea172728-6k_chinasxt.htm
2022-12-236-K2022-12-22REPORT OF FOREIGN PRIVATE ISSUERea170565-6k_chinasxt.htm
2022-10-126-K2022-10-12CURRENT REPORTea167002-6k_chinasxt.htm
2022-09-276-K2022-09-27REPORT OF FOREIGN PRIVATE ISSUERea166372-6k_chinasxt.htm
2022-05-136-K2022-05-13REPORT OF FOREIGN PRIVATE ISSUERea159933-6k_chinasxt.htm
2022-05-116-K2022-05-11FORM 6-Kea152500-6k_chinasxt.htm
2022-03-246-K2022-03-24FORM 6-Kea157304-6k_chinasxt.htm
2022-03-166-K2022-03-16REPORT OF FOREIGN PRIVATE ISSUERea156952-6k_chinasxt.htm
2022-02-096-K2022-02-08CURRENT REPORT OF FOREIGN PRIVATE ISSUERea155109-6k_chinasxt.htm
2022-01-316-K2022-01-31REPORT OF FOREIGN PRIVATE ISSUERea154708-6k_chinasxtphar.htm
2022-01-216-K2022-01-20REPORT OF FOREIGN PRIVATE ISSUERea154280-6k_chinasxtphar.htm
2022-01-146-K2021-09-30REPORT OF FOREIGN PRIVATE ISSUERea153974-6k_chinasxt.htm
2021-05-266-K2021-05-26FORM 6-Kea141768-6k_chinasxt.htm
2021-05-176-K2021-05-17REPORT OF FOREIGN PRIVATE ISSUERea141135-6k_chinasxt.htm
2021-04-086-K2020-04-08CURRENT REPORTea139224-6k_china.htm
2021-03-036-K2021-03-02REPORT OF FOREIGN PRIVATE ISSUERea136749-6k_chinasxt.htm
2021-02-166-K2021-02-16REPORT OF FOREIGN PRIVATE ISSUERea134932-6k_chinasxt.htm
2021-02-036-K2021-02-03REPORT OF FOREIGN PRIVATE ISSUERea134475-6k_chinasxt.htm
2021-01-286-K2020-09-30REPORT OF FOREIGN PRIVATE ISSUERea133557-6k_chinasxtpharma.htm
2020-12-036-K2020-12-01REPORT OF FOREIGN PRIVATE ISSUERea130801-6k_chinasxtpharma.htm
2020-07-106-K2020-07-10REPORT OF FOREIGN PRIVATE ISSUERf6k070920_chinasxtharma.htm
2020-05-226-K/A2019-09-30AMENDMENT TO REPORT OF FOREIGN PRIVATE ISSUERea122022-6ka_chinasxt.htm
2020-04-226-K2019-09-30REPORT OF FOREIGN PRIVATE ISSUERea120894-6k_chinasxt.htm
2020-03-316-K2020-03-31FORM 6-Kea120289-6k_chinasxtpharm.htm
2020-03-106-K2020-03-10REPORT OF FOREIGN PRIVATE ISSUERea119430-6k_chinasxt.htm
2020-03-046-K2020-03-03REPORT OF FOREIGN PRIVATE ISSUERea119278-6k_chinasxtpharm.htm
2020-01-316-K2020-01-31CURRENT REPORTf6k012920_chinasxtpharma.htm
2019-12-166-K2019-12-16REPORT OF FOREIGN PRIVATE ISSUERf6k121019_chinasxtpharma.htm
2019-07-316-K2019-07-31CURRENT REPORT OF FOREIGN ISSUERf6k073119_chinasxtpharma.htm
2019-05-036-K2019-05-03REPORT OF FOREIGN PRIVATE ISSUERf6k050319_chinasxtpharma.htm
2019-04-176-K2019-04-17REPORT OF FOREIGN PRIVATE ISSUERf6k041619_chinasxtpharma.htm
2019-03-286-K2019-03-27CURRENT REPORT OF FOREIGN ISSUERf6k032619_chinasxt.htm
Advertisement